Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed BSE that its Board of Directors will meet on Monday, 9 February 2026 at 2:00 PM at the registered office in Indore. The meeting will, among other things, consider and approve the Unaudited Quarterly Financial Results for the quarter ended 31 December 2025. The Board will also take on record the Limited Review Report by the auditors for the same quarter. Any other business items may be taken up with the Chair's permission. No financial figures or outcomes are disclosed in this intimation.
This is a routine regulatory filing ahead of the Q3 FY2025-26 results announcement. Shareholders should watch for the actual results on or after 9 February 2026 for any meaningful impact on the stock.